Counterweight

We're proud to share Naomi Brosnahan's achievements and insights from the Plexal Scaleup Programme! 🎓  Practical, people-focused, and packed with growth potential, we're excited to see how this shapes our next chapter! 🚀

Exciting to see our CEO at Google London this week with Innovate UK 🚀 Exploring how AI is shaping the future of metabolic health and digital innovation. #WomenInAI #HealthcareTech #Innovation #Leadership #MetabolicHealth

This International Women’s Day, we’re celebrating Dr. Naomi Brosnahan—the scientist, leader, and driving force behind Counterweight’s weight management and type 2 diabetes remission service. In 2009, Naomi’s pioneering work laid the foundation for our Type 2 Diabetes Remission Service, positioning Counterweight as the intervention provider for major clinical trials like DiRECT, STANDBy, and ReDiRECT. These world-class studies have reshaped how type 2 diabetes and weight is managed globally. 🌍 Her expertise and leadership continue to #AccelerateAction in metabolic health, empowering people worldwide to achieve sustainable weight loss and Type 2 diabetes remission. 👏 This #IWD2025, we’re proud to recognise Dr. Naomi Brosnahan for her contributions to science and healthcare, transforming lives through her work 👏 #IWD2025 #ExpertLed #EvidenceBased #DiabetesRemission #MetabolicHealth #Counterweight

Last week, our CEO, Naomi Brosnahan, had the privilege of attending the Women in Tech dinner in Edinburgh to celebrate International Women’s Day 2025. 🎉 Bringing together brilliant women in the industry, the evening was full of insightful conversations, new connections, and a shared commitment to driving change. The energy around the table was inspiring—proof that when women in tech come together, real impact happens. A huge thank you to Cooper Parry & Harper Macleod LLP for hosting such a fantastic event. Let’s continue to #AccelerateAction and push for greater progress in the tech world! #IWD2025 #WomenInTech #Leadership #DiversityInTech #AccelerateAction

🌟 New Research Published! 🌟 We are proud to share a recent publication co-authored by our CEO, Dr. Naomi Brosnahan, RD, PhD, which highlights the effectiveness of the Counterweight-Plus weight management programme (CWP) for patients with difficult-to-treat asthma and obesity. This research reinforces the impact of tailored interventions like the Counterweight programme in transforming the lives of individuals managing obesity and related health conditions. 🔗 Read the full study here: https://lnkd.in/dehqi_bC #ObesityResearch #ClinicalOutcomes #WeightManagement #HealthcareInnovation #Counterweight